Overview

Oxaliplatin in Gastric Cancer

Status:
Completed

Trial end date:
2006-07-01

Target enrollment:

Participant gender:

Summary

To determine the objective response to oxaliplatin/5FU/leucovorin combination chemotherapy in patients with advanced unresectable or metastatic gastric cancer.

Phase:

Phase 2

Details

Lead Sponsor:

Sanofi

Treatments:

Oxaliplatin